Daytrana for ADHD: Uses, Dosage & Side Effects

What is Daytrana?

Attention-deficit/hyperactivity disorder (ADHD) makes it difficult for many people in the United States to focus and pay attention to tasks. There are treatments available for individuals with ADHD. You can learn more about the symptoms of ADHD and treatment options in the NIMH ADHD treatment overview.

The Daytrana ADHD patch is a brand-name medication that contains methylphenidate in a transdermal patch form. This medication is a stimulant drug for treating symptoms of ADHD. Daytrana is FDA-approved to treat children and adolescents aged 6-17. It is not FDA-approved to treat ADHD in adults, but medical providers may prescribe it to adults with ADHD off-label.

Daytrana is a Schedule II controlled substance due to its potential for abuse and the development of substance use disorders. According to the FDA, methylphenidate is a central nervous system (CNS) stimulant drug that has high potential for abuse.

Here at ADHD Advisor, we provide services for adults who are 18 years of age nationwide. Let's take a closer look at how Daytrana works for ADHD management.

How Daytrana Works

The methylphenidate patch, Daytrana, is a stimulant medication that blocks the reuptake of norepinephrine and dopamine, two neurotransmitters that play a key role in attention and focus. It stimulates the CNS primarily in the prefrontal cortex.

The Daytrana ADHD patch provides continuous drug delivery through the skin, often placed on the hip. The medication is absorbed through the skin and can provide up to 9 hours of symptom relief. By absorbing the medication through the skin, it is released directly into the bloodstream. In this way, it avoids the first-pass metabolism that traditionally happens in the liver with oral medications. Transdermal patches often provide a longer working dose without taking multiple daily doses.

When the brain has increased levels of norepinephrine and dopamine, ADHD symptoms, such as inattention, focus issues, and hyperactivity, often improve. This increase can also help reduce impulsive behavior.

Who Can Take Daytrana

Daytrana is FDA-approved to treat children and young adults ages 6 to 17 with ADHD. It is not currently FDA-approved as a treatment for adults with ADHD, but clinicians may prescribe it off-label. Off-label means that doctors prescribe medication based on effects and their judgment.

Daytrana is an alternative to oral medications and can be beneficial for people who can't swallow pills well. ADHD Advisor only treats adults ages 18 and older.

Contraindications

There are some contraindications to be aware of before using a stimulant ADHD patch. Anyone with hypersensitivity to methylphenidate or any other ingredients in the product should not take Daytrana. Some other groups who shouldn't use ADHD transdermal medication include individuals who:

• Have glaucoma
• Have anxiety
• Have agitation
• Have motor tics or Tourette's syndrome
• Take MAOIs
• Have coronary artery disease
• Have severe hypertension

Individuals with bipolar disorder should be carefully monitored for psychosis symptoms, excess mania, or delusions or hallucinations. Individuals with heart conditions should also avoid taking Daytrana, as there is a risk of sudden death in this population.

Dosages and Administration

According to the FDA Daytrana prescribing information, the typical Daytrana dosage starts with one 10 mg patch and can be increased to 15-30 mg per day. The patch is placed on the hip area, once a day for up to 9 hours max. The effects usually take time to onset, so it is recommended to apply it to the body two hours before they are needed.

It's important to remove the stimulant ADHD patch after 9 hours to reduce insomnia and appetite suppression. The doctor may prescribe less than 9 hours as a means to help alleviate some of the unwanted side effects. This is beneficial for the evenings and late at night, as this medication continues to be absorbed even after the patch has been removed.

Remember, these are simply common dosages; only a clinician can determine what's a safe dosage for you.

Side Effects and Risks

As with any medication, along with benefits, there can be some side effects. Let's take a look at Daytrana's side effects.

Common Side Effects

Some of the more common side effects from using ADHD transdermal medication include the following: (MedlinePlus: methylphenidate patch)

• Irritability/aggression
• Appetite loss
• Upset stomach/nausea
• Headache
• Insomnia
• Increased heart rate
• Nervousness
• Dizziness
• Mood swings

Local skin reactions where the methylphenidate patch is placed are common, including redness, rash, itching, and irritated skin.

For more information concerning potential side effects, you can check with the DailyMed: Daytrana.

Serious Side Effects

Some serious side effects can occur when taking Daytrana, and if you experience any of these more serious side effects, you must alert your clinician right away. Some serious side effects include the following:

• Growth suppression
• Abuse/addiction
• Trouble breathing
• Allergic reaction symptoms include hives, itching, or swelling
• Mania symptoms, including delusions or hallucinations
• Heart attack
• Stroke
• Overdose
• Sudden death

If you experience any adverse side effects, let your provider know, and then report them to the FDA’s MedWatch reporting program. The MedWatch program is a system for reporting adverse effects of medications to the FDA, which helps to ensure the safety of medications on the market.

FDA-boxed Warning

Daytrana comes with a boxed warning. According to the DEA controlled substance schedules, Daytrana is a Schedule II controlled substance with a high potential for abuse and the development of a substance use disorder. Misuse of this medication can also lead to overdose and death. There are also possible cardiovascular reactions that may lead to sudden death.

In 2015, the FDA put out a warning that Daytrana can cause a permanent loss of skin color where the patch is placed on the skin.

Daytrana vs. Other ADHD Medications

Let’s compare the Daytrana ADHD patch to other ADHD medications. You can find more information at CHADD on ADHD medication delivery methods.

Daytrana vs Oral Methylphenidate (Ritalin, Concerta)

Daytrana is an ADHD transdermal medication in the form of methylphenidate. Ritalin and Concerta are oral pill forms of the same active ingredient. The stimulant ADHD patch is often chosen when patients have an issue swallowing pills.

Daytrana provides a longer and more flexible duration of side effects compared to the immediate-release version of Ritalin, which lasts about 4-6 hours. The Daytrana patch can last up to 9 hours. These two drugs have similar side effects, though the patch may also cause skin irritation.

Daytrana vs Amphetamines (Adderall, Vyvanse)

Daytrana and amphetamines are both stimulant drugs, but with different ingredients. Daytrana is a form of methylphenidate, while Adderall consists of a combination of mixed amphetamine and dextroamphetamine salts.

These medications have different tolerability, and Adderall or Vyvance may cause mood swings more than Daytrana. Daytrana provides a slower, more controllable dosage, and Adderall has either immediate-release or extended-release pill forms that can range from 4 hours to 12 hours, depending on which formula you are prescribed. Adderall is also used to treat narcolepsy.

Daytrana vs Non-stimulants

Daytrana ADHD patch is a stimulant medication with a different mechanism of action than non-stimulants. Most non-stimulant medication targets norepinephrine in some way to help the brain have more access to the neurotransmitter.

Stimulants typically target both norepinephrine and dopamine. Stimulants work faster than non-stimulants, which tend to have a slower effect. Non-stimulants have a much lower risk of abuse, though, so they may be better suited for people with a history of substance use disorder.

ADHD Care with ADHD Advisor: Stimulant Prescriptions in Select States

ADHD is a manageable condition. According to the CDC ADHD treatment guidance, ADHD can be successfully treated with therapy, non-stimulant medications, and stimulant medications. At ADHD Advisor, we provide therapy and non-stimulant treatment options nationwide for adults aged 18 years of age or older. Non-stimulant prescriptions may include Qelbree, guanfacine, clonidine, and Straterra.

In select states, stimulant options like Daytrana may be prescribed for adults if necessary, at the clinician's discretion. For example, online Adderall in Texas may be an option if you live there and your provider determines you need it. Similarly, your online doctor in Florida might prescribe youth with a stimulant medication if necessary.

When you use ADHD Advisor, you can receive yourADHD medication online. We will also help you with prescription fulfillment every month. We can send your prescriptions to your pharmacy of choice.

Please note that we do not bill insurance. We provide you with a superbill to document the services you received, and it is up to your insurance policy to determine whether you can be reimbursed.

Now, let's take a look at how to get diagnosed with ADHD using ADHD Advisor.

Step-by-Step Process

Let's go over how to get tested for ADHD online with ADHD Advisor. Here is our simple process.

1. Step one, you will take our online intake questionnaire.
2. Then, you will schedule your ADHD telehealth evaluation with one of our licensed clinicians.
3. Following your evaluation appointment, your provider will give you a treatment plan designed just for you. It may include therapy, non-stimulants, and stimulant medications, depending on whether you live in one of the states where we prescribe stimulants.
4. If you are an adult aged 18 or older and live in one of our supported states, you may receive a Daytrana prescription.
5. Finally, no matter what your treatment plan looks like, we will offer follow-up appointments to continue providing care. These follow-ups may include dosing adjustments, discussing improving or worsening symptoms, and any side effects that you may be experiencing from the medication.

Access, Cost & Insurance

Daytrana is available nationwide in the brand name form. The FDA has approved a generic version, but it may not yet be readily available to the public. The cost of Daytrana can vary, but a one-month prescription can cost around $500 a month without insurance. Many insurance policies may not cover Daytrana, but if they do, there's a chance you'll need prior authorization first.

The price of Daytrana is slightly higher than that of oral alternatives. Remember that ADHD Advisor does not bill your insurance company. We provide a superbill that you may submit for possible reimbursement, depending on your plan.

FAQs

Is Daytrana FDA-approved for adults?

No, Daytrana is currently only approved for use in children ages 6-7 with ADHD. However, some physicians may prescribe Daytrana to adults with ADHD off-label.

Is Daytrana addictive?

Yes, Daytrana is a Schedule II controlled substance and can be addictive according to the DEA and the FDA. Abuse and misuse may increase this risk. If you have a history of substance use disorder, you should let your clinician know before starting Daytrana.

Can an ADHD Advisor prescribe Daytrana?

ADHD Advisor can possibly prescribe Daytrana to an adult aged 18 or older who lives in one of the select states where we prescribe stimulant medications. However, it would be solely up to the clinician's judgment.

What are the patch benefits?

One benefit of wearing a transdermal ADHD patch is that you do not need to swallow any pills. Also, you’ll receive a steady dose of the medication throughout the day without requiring a second dose.

In addition, the patch can be taken off before the 9-hour mark; your doctor can work with you to utilize a flexible wear time. So, for example, they could have you remove it after six hours to prevent insomnia.

What are the main risks?

The main risks that can come from using a Daytrana patch can include developing a substance use disorder, overdose, sudden death, and skin irritation, including permanent pigment damage at the patch site.